4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid)

C61H66ClF13N10O14 — CID 175816503

IUPAC4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCN(CCCCN1CCN(CCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1)CCCOc1nc(N2C[C@H]3CC[C@@H](C2)N3)c2cc(Cl)c(-c3cc(O)cc4ccccc34)c(F)c2n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C53H62ClFN10O6.4C2HF3O2/c1-61(19-6-7-22-63-25-23-62(24-26-63)21-5-4-18-56-42-13-8-12-38-46(42)52(70)65(51(38)69)43-16-17-44(67)58-50(43)68)20-9-27-71-53-59-48-40(49(60-53)64-31-34-14-15-35(32-64)57-34)30-41(54)45(47(48)55)39-29-36(66)28-33-10-2-3-11-37(33)39;4*3-2(4,5)1(6)7/h2-3,8,10-13,28-30,34-35,43,56-57,66H,4-7,9,14-27,31-32H2,1H3,(H,58,67,68);4*(H,6,7)/t34-,35+,43?;;;;
InChIKeyUQTMOKBTULGNOA-IDTQCSCVSA-N
MW1445.68 g/mol
LogP8.81
Rot. Bonds19

About 4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid)

4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid) (PubChem CID 175816503) has the molecular formula C61H66ClF13N10O14 and a molecular weight of 1445.68 g/mol. Its IUPAC name is 4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid).

Molecular Properties

Compound Name4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid)
PubChem CID175816503
Molecular FormulaC61H66ClF13N10O14
Molecular Weight1445.68 g/mol
Exact Mass1444.42
IUPAC Name4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCN(CCCCN1CCN(CCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1)CCCOc1nc(N2C[C@H]3CC[C@@H](C2)N3)c2cc(Cl)c(-c3cc(O)cc4ccccc34)c(F)c2n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C53H62ClFN10O6.4C2HF3O2/c1-61(19-6-7-22-63-25-23-62(24-26-63)21-5-4-18-56-42-13-8-12-38-46(42)52(70)65(51(38)69)43-16-17-44(67)58-50(43)68)20-9-27-71-53-59-48-40(49(60-53)64-31-34-14-15-35(32-64)57-34)30-41(54)45(47(48)55)39-29-36(66)28-33-10-2-3-11-37(33)39;4*3-2(4,5)1(6)7/h2-3,8,10-13,28-30,34-35,43,56-57,66H,4-7,9,14-27,31-32H2,1H3,(H,58,67,68);4*(H,6,7)/t34-,35+,43?;;;;
InChIKeyUQTMOKBTULGNOA-IDTQCSCVSA-N
XLogP8.81
TPSA325.01 Ų
H-Bond Donors8
H-Bond Acceptors18
Rotatable Bonds19
Heavy Atoms99
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001445.68
LogP ≤ 58.81
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid)?
The IUPAC name of 4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid) (CID 175816503) is 4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid).
What is the SMILES notation for 4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid)?
The canonical SMILES for 4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid) is CN(CCCCN1CCN(CCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1)CCCOc1nc(N2C[C@H]3CC[C@@H](C2)N3)c2cc(Cl)c(-c3cc(O)cc4ccccc34)c(F)c2n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.
What is the InChIKey of 4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid)?
The InChIKey is UQTMOKBTULGNOA-IDTQCSCVSA-N. The full InChI is InChI=1S/C53H62ClFN10O6.4C2HF3O2/c1-61(19-6-7-22-63-25-23-62(24-26-63)21-5-4-18-56-42-13-8-12-38-46(42)52(70)65(51(38)69)43-16-17-44(67)58-50(43)68)20-9-27-71-53-59-48-40(49(60-53)64-31-34-14-15-35(32-64)57-34)30-41(54)45(47(48)55)39-29-36(66)28-33-10-2-3-11-37(33)39;4*3-2(4,5)1(6)7/h2-3,8,10-13,28-30,34-35,43,56-57,66H,4-7,9,14-27,31-32H2,1H3,(H,58,67,68);4*(H,6,7)/t34-,35+,43?;;;;.
What are the key properties of 4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid)?
4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid) has a molecular weight of 1445.68 g/mol, XLogP of 8.81, 19 rotatable bonds, 8 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[4-[4-[3-[6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-7-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl]oxypropyl-methylamino]butyl]piperazin-1-yl]butylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;tetrakis(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 175816503), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).